My Child Has Bravely Fought Her Brain Tumor. She’s Still Waiting for a Cure

As her young daughter battles a brain tumor, a mother advocates for more research — and funding — to combat childhood cancers of all kinds.

1:00 PM

Author | Shannon Hennessey

Our daughter, Ally, has been in cancer treatment most of her life.

She was diagnosed with a brain tumor and began chemotherapy at age 3. Her first chemotherapy treatment was before her first day of preschool.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Our initial line of defense were the chemo drugs vincristine, which came on the market in 1961, and carboplatin, which became available in 1986.

To put that into context, consider that the first disposable diapers came out in 1961, a time when people were watching The Andy Griffith Show on television. In 1986, the world was introduced to the laptop computer; kids were playing with Nintendo.

Think of how far those technologies have evolved since then.

And yet we're still using the same drugs to fight childhood cancer. Of all the federal funding for cancer research, just 4 percent goes toward pediatrics.

In Ally's case, the drugs stopped working after about one year of treatment. That put us back at square one, resetting her treatment with a new plan of attack. Then, when that didn't work, another plan. Then another.

In all, we tried four experimental protocols to combat her cancer between 2012 and 2014.

With each new drug, we signed more consent forms agreeing to things no parent wants to imagine but feeling unquestionably confident that the risks would be worth it to have our daughter here and healthy with us.

SEE ALSO: Chad Carr Movement Accelerating Childhood Brain Cancer Research

Ally (pictured above with Michigan Medicine pediatric oncologist Carl Koschmann, M.D.) completed treatment Aug. 4, 2014. For a brief moment, we had a break and life felt normal.

Then, in January 2016, her tumor became more aggressive.

She tried another drug that worked for a year and became less effective at controlling her tumor. Unfortunately, she's tried every available protocol. We find ourselves yet again waiting for something new to try, for a new drug to enter clinical trials so we have an option for Ally.

We don't want people to feel sympathy for us. In fact, we consider ourselves among the lucky ones. Ally, now 9 years old, is here with us  going to school, playing with friends and sharing holidays with the family.

Not every parent can say the same. In 2017, there are still too many childhood cancers that are terminal and we have lost so many friends to the disease.

But during Childhood Cancer Awareness Month in September, or anytime you hear someone talking about how children are waiting for cures, please know that it's not an abstract saying. Kids are waiting for cures, and we're proof that it isn't just lip service.

Ally is still waiting.

University of Michigan C.S. Mott Children's Hospital strives to find better, safer cures for childhood cancer. Learn how you can join the fight to Block Out Cancer


More Articles About: Children's Health Cancer Research Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories purple all notifications on phone teen sleeping in bed with phone next to them
Health Lab
Study: Average teen received more than 200 app notifications a day
A Michigan Medicine expert explains more of a report’s key findings on cell phone use and how parents can support a healthy use of technology.
kids on the floor
Health Lab
Protecting children from poor air quality: 6 things to know
As smoke from Canada's historic wildfires triggers poor air quality alerts across the country, many parents worry about the impact on their child’s health, a national poll suggests. Here, a Michigan Medicine expert provides six ways to help reduce exposure.
cancer cell
Health Lab
Language barriers in cancer care
Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 
kids in classroom playing
Health Lab
Sensitive parenting and preschool attendance may promote academic resilience in late preterm infants
Michigan Medicine research tracks academic trajectories of late preterm infants from infancy to kindergarten and identifies developmental risks and how to best promote resilience
blood sample
Health Lab
Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence
Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner. The papers, published in Cancer and Oral Oncology, offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow, and provide a framework for a new, more sensitive blood test that could help in this monitoring.
nanoparticles floating green blue
Health Lab
Gene therapy for brain tumor shows promising early results in humans
Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.